OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Covalent targeted radioligands potentiate radionuclide therapy
Xi‐Yang Cui, Zhu Li, Ziren Kong, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 206-213
Closed Access | Times Cited: 49
Xi‐Yang Cui, Zhu Li, Ziren Kong, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 206-213
Closed Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
Porphyrin-Engineered 125I-Nanoseeds as a Prototype for Immunogenic Brachytherapy
Zhiyu Tu, Ziyang Sang, Xu Yang, et al.
Journal of the American Chemical Society (2025)
Closed Access
Zhiyu Tu, Ziyang Sang, Xu Yang, et al.
Journal of the American Chemical Society (2025)
Closed Access
Localized In Vivo Prodrug Activation Using Radionuclides
Jeremy M. Quintana, Fangchao Jiang, Mikyung Kang, et al.
Journal of Nuclear Medicine (2025) Vol. 66, Iss. 1, pp. 91-97
Open Access
Jeremy M. Quintana, Fangchao Jiang, Mikyung Kang, et al.
Journal of Nuclear Medicine (2025) Vol. 66, Iss. 1, pp. 91-97
Open Access
Covalent multi-targeted radiopharmaceuticals for enhanced tumor theranostics
Yirui Guo, Zhengzhong Lv, Yuqi Zhang, et al.
Science China Chemistry (2025)
Closed Access
Yirui Guo, Zhengzhong Lv, Yuqi Zhang, et al.
Science China Chemistry (2025)
Closed Access
Discovery of Thioether-Cyclized Macrocyclic Covalent Inhibitors by mRNA Display
Tong Lan, Cheng Peng, Xiyuan Yao, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 34, pp. 24053-24060
Closed Access | Times Cited: 3
Tong Lan, Cheng Peng, Xiyuan Yao, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 34, pp. 24053-24060
Closed Access | Times Cited: 3
Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives
Ziyue Yu, Zeng Jiang, Xuebo Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116787-116787
Closed Access | Times Cited: 3
Ziyue Yu, Zeng Jiang, Xuebo Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116787-116787
Closed Access | Times Cited: 3
Total Body PET/CT: A Role in Drug Development?
Xiangxi Meng, Xiangxing Kong, Runze Wu, et al.
Seminars in Nuclear Medicine (2024)
Closed Access | Times Cited: 3
Xiangxi Meng, Xiangxing Kong, Runze Wu, et al.
Seminars in Nuclear Medicine (2024)
Closed Access | Times Cited: 3
Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis
Zhibin Guo, Xuanyu Wang, Yi Han, et al.
ACS Central Science (2024) Vol. 10, Iss. 12, pp. 2321-2330
Open Access | Times Cited: 3
Zhibin Guo, Xuanyu Wang, Yi Han, et al.
ACS Central Science (2024) Vol. 10, Iss. 12, pp. 2321-2330
Open Access | Times Cited: 3
New Applications of Sulfonyl Fluorides: A Microcosm of the Deep Integration of Chemistry and Biology in Drug Design
Shaoqing Du, Xueping Hu, Craig W. Lindsley, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Shaoqing Du, Xueping Hu, Craig W. Lindsley, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Preclinical evaluation and first-in-human study of [18F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts
S. Liu, Ziqi Zhang, Jiawei Zhong, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
S. Liu, Ziqi Zhang, Jiawei Zhong, et al.
EJNMMI Research (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
CTR-FAPI PET enables precision management of medullary thyroid carcinoma
Ziren Kong, Zhu Li, Xi‐Yang Cui, et al.
Cancer Discovery (2024) Vol. 15, Iss. 2, pp. 316-328
Closed Access | Times Cited: 2
Ziren Kong, Zhu Li, Xi‐Yang Cui, et al.
Cancer Discovery (2024) Vol. 15, Iss. 2, pp. 316-328
Closed Access | Times Cited: 2
Development and Evaluation of DOTA-FAPI-Maleimide as a Novel Radiotracer for Tumor Theranostic with Extended Circulation
Lixia Feng, Wenzhu Hu, Xinying Zeng, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4386-4394
Closed Access | Times Cited: 1
Lixia Feng, Wenzhu Hu, Xinying Zeng, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4386-4394
Closed Access | Times Cited: 1
Development and biological evaluation of PSMA/FAP dual targeting radiotracers for prostate cancer imaging
Haodong Hou, Jingyue Gao, Yuze Ma, et al.
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 19, pp. 6476-6485
Closed Access | Times Cited: 1
Haodong Hou, Jingyue Gao, Yuze Ma, et al.
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 19, pp. 6476-6485
Closed Access | Times Cited: 1
Trends in cancer imaging
Xinyuan Zhou, Binyu Shi, Gang Huang, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 1
Xinyuan Zhou, Binyu Shi, Gang Huang, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 1
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Peter J. H. Scott, Iván Peñuelas, Ana María Rey, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Peter J. H. Scott, Iván Peñuelas, Ana María Rey, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
211At radiolabeled APBA-FAPI for enhanced targeted-alpha therapy of glioma
Tianzhen Ye, Yuying Yu, Guofeng Qu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116919-116919
Closed Access | Times Cited: 1
Tianzhen Ye, Yuying Yu, Guofeng Qu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116919-116919
Closed Access | Times Cited: 1
Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing immunotherapy
Kaiyue Zuo, Naiyu Liu, Peng Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117664-117664
Closed Access | Times Cited: 1
Kaiyue Zuo, Naiyu Liu, Peng Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117664-117664
Closed Access | Times Cited: 1
Localizedin vivoprodrug activation using radionuclides
Jeremy M. Quintana, Fangchao Jiang, Minji Kang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Jeremy M. Quintana, Fangchao Jiang, Minji Kang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rational Modifications on N-(4-Quinolinoyl)-Gly-2-Cyanopyrrolidine to Develop Fibroblast Activation Protein-Targeted Radioligands with Improved Affinity and Tumor Uptake
Xiayang Qiu, Qianqian Gan, Tianxiong Ji, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117011-117011
Closed Access
Xiayang Qiu, Qianqian Gan, Tianxiong Ji, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117011-117011
Closed Access
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
Andreas Helisch, Clemens Kratochwil, Christian Kleist, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268386-jnumed.124.268386
Closed Access
Andreas Helisch, Clemens Kratochwil, Christian Kleist, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268386-jnumed.124.268386
Closed Access
Medicinal Chemistry Education: Emphasize Fundamentals and Skillfully Integrate Knowledge
Shaoqing Du, Xueping Hu, Craig W. Lindsley, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19929-19931
Open Access
Shaoqing Du, Xueping Hu, Craig W. Lindsley, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19929-19931
Open Access
Ultrasound Guided Local Delivery of Bioorthogonal PDL1 Degrader for Enhanced Immunotherapy
Lantian Wang, Zhaoyou Liu, Panpan Ji, et al.
Small (2024)
Closed Access
Lantian Wang, Zhaoyou Liu, Panpan Ji, et al.
Small (2024)
Closed Access
Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer
Xinlin Wang, Xiaoyang Zhang, Xiaojun Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access
Xinlin Wang, Xiaoyang Zhang, Xiaojun Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access
Astatine-211 and Actinium-225: two promising nuclides in targeted alpha therapy
Dashan Zuo, Hui Wang, Boyi Yu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Dashan Zuo, Hui Wang, Boyi Yu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Integrating targeting and drug retention: A promising approach for cancer treatment
Shenqiang Wang, Zhiyuan Zhong
Journal of Controlled Release (2024) Vol. 378, pp. 247-249
Closed Access
Shenqiang Wang, Zhiyuan Zhong
Journal of Controlled Release (2024) Vol. 378, pp. 247-249
Closed Access
Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy
Ying‐Jun Zhang, Paolo Coghi, Zimo Ren, et al.
Medicinal Research Reviews (2024)
Closed Access
Ying‐Jun Zhang, Paolo Coghi, Zimo Ren, et al.
Medicinal Research Reviews (2024)
Closed Access
